Transgene SA (EPA:TNG)
France · Delayed Price · Currency is EUR 0.7140
+0.0030 (0.42%)
Aug 3, 2026, 12:42 PM CET
Transgene Employees
Transgene had 145 employees as of December 31, 2025. The number of employees increased by 1 or 0.69% compared to the previous year.
Employees
145
Change (1Y)
1
Growth (1Y)
0.69%
Revenue / Employee
€49,724
Profits / Employee
€258,786
Market Cap
194.73M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 145 | 1 | 0.69% |
| Dec 31, 2024 | 144 | 3 | 2.13% |
| Dec 31, 2023 | 141 | -5 | -3.42% |
| Dec 31, 2022 | 146 | 3 | 2.10% |
| Dec 31, 2021 | 143 | 4 | 2.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Cellectis | 229 |
| DBV Technologies | 170 |
| Innate Pharma | 164 |
| Adocia | 73 |
| OSE Immunotherapeutics | 64 |
| Sensorion | 63 |
| MaaT Pharma | 59 |
Transgene News
- 4 weeks ago - Transgene Transcript: Status update - Transcripts
- 4 weeks ago - Transgene Press release: Status update - Filings
- 4 weeks ago - Transgene Slides: Status update - Filings
- 5 weeks ago - Transgene Slides: Investor presentation - Filings
- 3 months ago - Transgene Earnings release: Q1 2026 - Filings
- 4 months ago - Transgene Earnings Call Transcript: H2 2025 - Transcripts
- 4 months ago - Transgene Annual report: H2 2025 - Filings
- 4 months ago - Transgene Earnings release: H2 2025 - Filings